Cargando…
Establishment and evaluation of a nomogram for predicting the survival outcomes of patients with diffuse large B-cell lymphoma based on International Prognostic Index scores and clinical indicators
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma, treatment outcomes of patients vary greatly. The current International Prognostic Index (IPI) is not enough to distinguish patients with poor prognosis, and genetic testing is very expensive, so a inexpensive r...
Autores principales: | Chen, Yao, Xu, Jiaqin, Meng, Jiao, Ding, Mingshuang, Guo, Yiwei, Fu, Dongwei, Liu, Aichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929781/ https://www.ncbi.nlm.nih.gov/pubmed/36819580 http://dx.doi.org/10.21037/atm-22-6023 |
Ejemplares similares
-
Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?
por: AKGÜN ÇAĞLIYAN, Gülsüm, et al.
Publicado: (2021) -
Prognostic Factors and Nomogram Predicting Survival in Diffuse Astrocytoma
por: Tunthanathip, Thara, et al.
Publicado: (2020) -
Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma
por: Go, Se-Il, et al.
Publicado: (2023) -
Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma
por: Hao, Xiaoxiao, et al.
Publicado: (2017) -
Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma
por: Yan, Jiaqin, et al.
Publicado: (2022)